Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes

Authors:
  • GCGregory A. Curt
    Gregory A. Curt
  • DCDesmond N. Carney
    Desmond N. Carney
  • KCKenneth H. Cowan
    Kenneth H. Cowan
  • JJJacques Jolivet
    Jacques Jolivet
  • BBBrenda D. Bailey
    Brenda D. Bailey
  • JDJames C. Drake
    James C. Drake
  • CKChien Song Kao-Shan
    Chien Song Kao-Shan
  • JMJohn D. Minna
    John D. Minna
  • BCBruce A. Chabner
    Bruce A. Chabner

Abstract
Resistance to antineoplastic drugs may develop through a variety of mechanisms, including deletion of membrane-transport mechanisms, an increase in target-enzyme concentration, or a deletion of an essential drug-activating enzyme. One unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to elevated levels of the protein. In studies of cultured experimental tumor-cell lines, resistance to a variety of toxic substances, including cadmium1 and the antineoplastic drugs N-phosphonacetyl-L-aspartate2 and methotrexate,3 has been ascribed to gene amplification.The process of gene amplification in methotrexate-resistant mammalian cells may occur within a single chromosome, producing an . . .

This publication has 25 references indexed in Scilit: